Mixed backbone oligonucleotides: Improvement in oligonucleotide-induced toxicity in vivo

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 2, 1998, Pages 135-139

  Agrawal, Sudhir ^a   Zhao, Qiuyan ^a  

^a HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

CONFERENCE PAPER; GENE TARGETING; PRIORITY JOURNAL;

EID: 0031948835     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.135     Document Type: Conference Paper

References (20)

1. AGRAWAL, S. (1996). Antisense oligonucleotides: Towards clinical trials Trends Biotechnol. 14, 376-387.
2. AGRAWAL, S., ZHAO, Q., JIANG, Z., OLIVER, C., GILES, H., HEATH, J., and SEROTA, D. (1997a). Toxicological effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats. Antisense Nucleic Acid Drug Dev. 7, 575-584.
3. AGRAWAL, S., JIANG, Z., ZHAO, Q., SHAW, D., CAL, Q., ROSKEY, A., CHANNAVAJJALA, L., SAXINGER, C., and ZHANG, R. (1997b). Mixed-backbone oilgonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Prod. Nat. Acad. Sci. USA 94, 2620-2625.
4. AKHTAR, S., and AGRAWAL, S. (1997). In vivo studies with antisense oligonucleotide. Trends Pharm Sci. 18, 12-18.
5. BENNETT, C.F. (1998). Antisense oligonucleotides: Is the glass half full or half empty? Biochem. Pharmacol. 55, 9-19.
6. BIRON, C.A. (1994). Cytokines in the generation of immune responses and resolution of virus infection. Crit. Rev. Immunol. 6, 530-538.
7. CHO-CHUNG, Y.S. (1997). Antisense-protein kinase A: A single-gene-based therapeutic approach. Antisense Nucleic Acid Drug Dev. 7, 495-502.
8. GALBRAITH, W.M., HOBSON, W.C., GICLAS, P.C., SCHECHTER, P.J., and AGRAWAL, S. (1994). Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res. Dev. 4, 201-206.
9. HENRY, S.P., GICLAS, P.C., LEEDS, J., PANGBURN, M., AULETTA, C., LEVIN, A.A., and KORNBRUST, D.J. (1997a). Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: Potential mechanism of action. J. Pharmacol. Exp. Ther. 281, 810-816.
10. HENRY, S.P., ZUCKERMAN, J.E., ROJKO, J., HALL, W.C., HARMAN, R.J., KITCHEN, D., and CROOKE, S.T. (1997b). Toxicological properties of several novel oligonucleotide analogs in mice. Anti-Cancer Drug Design 12, 1-14.
11. JANSEN, B., WADL, H., INOUE, S.A., TRULZSCH, B., SELZER, E., DUCHENE, M., EICHLER, H., WOLFF, K., and PEHAMBERGER, H. (1995). Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a non-antisense mechanism. Antisense Res. Dev. 5, 271-277.
12. KRIEG, A.M., YI, A.E., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
13. LE, J.M., and VILCEK, J. (1989). Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61, 588-602.
14. LUSSO, P., and GALLO, R.C. (1996). Role of β-chemokines in suppressing HIV replication. Science 274, 1393-1395.
15. NESTEROVA, M., and CHO-CHUNG, Y.S. (1995). A single-injection protein kinase A-directed antisense treatment to inhibit tumor growth. Nature Med 1, 528-533.
16. PISETSKY, D.S. (1996). Immune activation by bacterial DNA: A new genetic code [Review]. Immunity 5, 303-310, and references therein.
17. SARMIENTO, U.M., PEREZ, J.R., BECKER, J.M., and NARAYANA, R. (1994). In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res. Dev. 4, 99-107.
18. SHAW, D.R., RUSTAGI, P.K., KANDIMALLA, E.R., MANNING, A.N., JIANG, Z., and AGRAWAL, S. (1997). Effects of synthetic oligonucleotides on human complement and coagulation. Biochem. Pharmacol. 53, 1123-1132.
19. ZHAO, Q., TEMSAMANI, J., IADAROLA, P.L., JIANG, Z.W., and AGRAWAL, S. (1996). Effect of different chemical modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51, 173-182.
20. ZHAO, Q., TEMSAMANI, J., ZHOU, R.Z., and AGRAWAL, S. (1997). Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug Dev. 7, 495-502.